Ioannis aifantis
WebIoannis Aifantis. Alternative polyadenylation and cancer immunotherapy : Coffee Break / Poster Viewing : 11:00 AM. Session VIII. RNA therapeutics. Chair: Judy Lieberman. 12:00 PM. Judy Lieberman. Tumor-targeted gene knockdown for cancer immunotherapy : Frank Slack. Toward personalized microRNA therapeutics in cancer : Andrea Kasinski WebFind Ioannis Aifantis's accurate email address in Adapt.io. Currently working as Pathology, School of Medicine at Nyu Hospitals Center in New york, United States. Connect with intelligence
Ioannis aifantis
Did you know?
Web11 jan. 2014 · Ioannis Aifantis AGE: 66 • Berlin AIFANTIS- Ioannis, age 66 of Berlin on January 9, 2014. Beloved husband of Sophia (nee Polichronidis). Devoted father of Spiro of Marlton, ... WebIoannis Aifantis, M.D., has made several fundamental observations on how the pre-TCR mediates T cell development. He has also made contributions to our understanding of how progenitor cells commit to the T cell lineage.
Web10 jan. 2024 · Contact Phone 212-263-9898 Email Ioannis.Aifantis @nyulangone.org Academic office 550 First Avenue, Smilow Research Building 13th Floor, Room 1303 New York, NY 10016 Lab Website Aifantis Lab Is this … WebDr. Jochen Imig studied Biology at Saarland University, Saarbrücken and performed his Ph.D. work at Saarland University Medical School (Institute of Virology) in collaboration with the University Hospital Zurich, Switzerland (Department of Oncology). He then moved for a Post-Doctoral position to ETH Zurich under the supervision of Profs.
WebIoannis Vardoulakis mainly investigates Stress, Mechanics, Hydrodynamic forces, Erosion and Fluid dynamics. His work on Hydrostatic stress as part of his general Stress study is frequently connected to Asymmetry, thereby bridging the divide between different branches of … WebWelcome to the Aifantis Lab. Our laboratory studies the molecular mechanisms driving normal stem cell differentiation and malignant transformation. More specifically, we are using the hematopoietic system as our model of study and focus on the genomic, epigenetic and proteomic regulation of hematopoietic stem cell differentiation and induction ...
WebJames M. Crawford, Maria E. Aguero-Rosenfeld, Ioannis Aifantis, Evan M. Cadoff, Joan F. Cangiarella, Carlos Cordon-Cardo, Melissa Cushing, Aldolfo Firpo-Betancourt ...
[email protected]. The main focus of Professor Aifantis' laboratory is the study of the mechanisms of hematopoietic stem cell (HSC) differentiation and transformation. The research is focused on three signaling pathways: Notch, Hedgehog (Hh) and SCF ubiquitin ligase signaling cascades, and their role in stem cell biology and function. paint at walmart for kidsWebReview EmergingrolesfortRNAsinhematopoiesisand hematological malignancies Anna K. Lee,1 Iannis Aifantis,1,* and Palaniraja Thandapani1 ... paint at walmartWebIannis Aifantis. Professor and Chair, Department of Pathology 550 First Avenue, Smilow 1307 New York, NY 10016 Ph. 212 263 9898 Email: [email protected] http://pathology.med.nyu.edu subscriptions for new momsWebThe Prize Committee consists of eight personalities active in academic research. Its members are the following: Ioannis Aifantis, Professor of Pathology, NYU School of Medicine. Theodora Varvarigou, Professor at the School of Electrical and Computer Engineering, National Technical University of Athens. subscriptions flowersWebAlthough deregulation of transfer RNA (tRNA) biogenesis promotes the translation of pro-tumorigenic mRNAs in cancers1,2, the mechanisms and consequences of tRNA deregulation in tumorigenesis are poorly understood. Here we use a CRISPR-Cas9 screen to focus on genes that have been implicate … subscriptions for elderly parentsWeb13 jan. 2014 · Ioannis Aifantis AIFANTIS- Ioannis, age 66 of Berlin on January 9, 2014. Beloved husband of Sophia (nee Polichronidis). Devoted father of Spiro of Marlton, Lambros of Greece and Elena of Williamstown. Dear brother of Athena Aifantis, Kostantina, and Theodora Katsaba all of Greece. subscriptions for christmas gifts[email protected] [email protected]. # Contributed equally. PMID: 31048321 PMCID: PMC6606342 DOI: 10.1158/2159-8290.CD-19-0117 Abstract The BCL2 family plays important roles in acute myeloid leukemia (AML). Venetoclax, a selective BCL2 inhibitor, has received FDA approval for the treatment of AML. subscriptions for college students